Clinical Trial Update: Steady-state Bioequivalence Study of Aripiprazole for Injection in Patients With Schizophrenia. [NA]

View source ↗

Summary

A steady-state bioequivalence study of an injectable aripiprazole formulation in patients with schizophrenia, with the study status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | Conditions: Schizophrenia | NA | Status: NOT_YET_RECRUITING